BMV:XBI Holdings Information

BMV:XBI is an equity ETF with a total of 129 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 3.57%, Halozyme Therapeutics at 2.82%, Incyte at 2.78%, Insmed at 2.73%, and United Therapeutics at 2.65%.

Total Holdings

129

Top 10 Percentage

27.24%

Asset Class

Equity

ETF Category

Health Care

Assets

4.56B

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	3.57%	374,170
2	HALO	Halozyme Therapeutics, Inc.	2.82%	2,074,507
3	INCY	Incyte Corporation	2.78%	1,622,592
4	INSM	Insmed Incorporated	2.73%	1,140,135
5	UTHR	United Therapeutics Corporation	2.65%	404,040
6	REGN	Regeneron Pharmaceuticals, Inc.	2.64%	215,378
7	BMRN	BioMarin Pharmaceutical Inc.	2.55%	1,954,411
8	ABBV	AbbVie Inc.	2.54%	583,390
9	NBIX	Neurocrine Biosciences, Inc.	2.48%	899,695
10	GILD	Gilead Sciences, Inc.	2.47%	1,022,103
11	AMGN	Amgen Inc.	2.39%	382,805
12	BIIB	Biogen Inc.	2.35%	839,548
13	MRNA	Moderna, Inc.	2.35%	4,025,637
14	BBIO	BridgeBio Pharma, Inc.	2.30%	2,286,845
15	EXEL	Exelixis, Inc.	2.21%	2,696,410
16	MDGL	Madrigal Pharmaceuticals, Inc.	2.14%	285,221
17	NTRA	Natera, Inc.	2.07%	669,883
18	VRTX	Vertex Pharmaceuticals Incorporated	2.03%	246,913
19	EXAS	Exact Sciences Corporation	1.90%	2,007,148
20	ROIV	Roivant Sciences Ltd.	1.74%	6,867,467
21	CRSP	CRISPR Therapeutics AG	1.63%	1,328,972
22	RNA	Avidity Biosciences, Inc.	1.54%	1,474,938
23	CYTK	Cytokinetics, Incorporated	1.52%	1,969,996
24	IONS	Ionis Pharmaceuticals, Inc.	1.51%	1,682,621
25	VKTX	Viking Therapeutics, Inc.	1.43%	1,830,697

As of Aug 7, 2025

Showing 25 of 129

Subscribe to see the full list